SQZ Biotechnologies (NYSE:SQZ) vs. Precision BioSciences (NASDAQ:DTIL) Critical Contrast
SQZ Biotechnologies (NYSE:SQZ – Get Free Report) and Precision BioSciences (NASDAQ:DTIL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast ...
Alamar Biosciences Unveils NULISAseq Inflammation Panel AQ
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce ...
Precision Biosciences' general counsel sells shares worth $42,765
Dario Scimeca, General Counsel and Secretary of Precision BioSciences Inc . (NASDAQ:DTIL), a biotechnology company with a market capitalization of $38 million and currently trading at $4.97, executed ...
Precision Biosciences chief research officer sells $49,274 in stock
The filing also noted Smith's indirect ownership of 7,931 shares through a Charitable Remainder Unitrust. The company's market capitalization stands at $38.08 million, with a P/E ratio of 3.28, ...
MBX Biosciences to Participate in Upcoming February Investor Conferences
CARMEL, Ind., Jan. 23, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the ...
Yahoo Finance5d
Precision BioSciences, Inc. (DTIL)
DURHAM, N.C., January 09, 2025--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...
Cogent Biosciences (NASDAQ:COGT) Shares Down 4.2% – What’s Next?
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report)’s share price traded down 4.2% during mid-day trading on Friday . The stock traded as low as $8.54 and last traded at $8.52. 272,611 shares ...
Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia
Only dual route gene transfer therapy in development to treat Friedreich’s ataxia with FDA IND clearance and Fast Track ...
Persephone Biosciences Announces First Subject Enrolled in ARTEMIS Clinical Trial of New Infant Synbiotic
Persephone Biosciences Inc., a commercial company restoring and reinvigorating the human gut microbiome through clinically validated synergistic synbiotics, today announced that the first subject has ...
Alamar Biosciences, Inc.: Alamar Biosciences Unveils NULISAseq Inflammation Panel AQ
Revolutionary tool enables comprehensive quantitation of immune response in clinical cohorts. FREMONT, Calif., Jan. 22, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision ...
IDEAYA Biosciences: Promising Pipeline and Strategic Growth Drive Buy Rating
BTIG analyst Justin Zelin has maintained their bullish stance on IDYA stock, giving a Buy rating on January 15.Invest with Confidence: Follow ...
Pharmabiz4d
Solid Biosciences’ AAV-based gene therapy candidate, SGT-212 for Friedreich’s ataxia receives US FDA fast track designation
Solid Biosciences’ AAV-based gene therapy candidate, SGT-212 for Friedreich’s ataxia receives US FDA fast track designation: Charlestown, Massachusetts Thursday, January 23, 2 ...